Close

Eli Lilly & Co. (LLY) Receives Positive CHMP Opinion on Olaratumab Combo in Adv. STS

September 16, 2016 7:24 AM EDT Send to a Friend
Eli Lilly and Company (NYSE: LLY) announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login